Alberta, Canada: A study by University of Alberta researcher Scot Simpson has shed light on the use of aspirin as a preventative measure for cardiovascular disease and reoccurrence in patients with diabetes.
According to the data collected from the clinical trials that taking aspirin as a course of treatment would prevent a first or recurrent heart attack or stroke.
During the study of these diabetic patients Simpson discovered that patients who suffered with previous heart attack were taking low dose of aspirin daily had very little benefit in terms of prevention of a second heart attack or a decreased risk of mortality.
However, in patients taking higher doses of aspirin, the risk of a repeat heart attack or death was significantly lower.
Simpson said that in these 21 studies we focused specifically on diabetic patient who had suffered a previous heart attack or stroke to measure the ability of aspirin to prevent a second event. We found that, if those patients took up to 325 milligrams of aspirin per day, they had a 23 percent lower risk of death.